This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2009 Aug 4;151(3):210-1.

doi: 10.7326/0003-4819-151-3-200908040-00010.

Modeling comparative effectiveness and the value of research

Anirban Basu, David Meltzer

PMID: 19652188
DOI: 10.7326/0003-4819-151-3-200908040-00010

Editorial

Modeling comparative effectiveness and the value of research

Anirban Basu et al. Ann Intern Med. 2009.

. 2009 Aug 4;151(3):210-1.

doi: 10.7326/0003-4819-151-3-200908040-00010.

Authors

Anirban Basu, David Meltzer

PMID: 19652188
DOI: 10.7326/0003-4819-151-3-200908040-00010

No abstract available

PubMed Disclaimer

Comment on

When to start antiretroviral therapy in resource-limited settings.
Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, Paltiel AD, Anglaret X, Weinstein MC, Losina E; CEPAC (Cost-Effectiveness of Preventing AIDS Complications)-International Investigators. Walensky RP, et al. Ann Intern Med. 2009 Aug 4;151(3):157-66. doi: 10.7326/0003-4819-151-3-200908040-00138. Epub 2009 Jul 20. Ann Intern Med. 2009. PMID: 19620143 Free PMC article.

Similar articles

Cost-effectiveness evaluation to inform clinical trial design.
Ribaudo HJ. Ribaudo HJ. Clin Infect Dis. 2007 Oct 15;45(8):1071-3. doi: 10.1086/521934. Epub 2007 Sep 4. Clin Infect Dis. 2007. PMID: 17879927 No abstract available.
A decision tree to help determine the best timing and antiretroviral strategy in HIV-infected patients.
Piroth L, Fournel I, Mahy S, Yazdanpanah Y, Rey D, Rabaud C, Faller JP, Hoen B, Fardeheb M, Quantin C, Chavanet P, Binquet C; Groupe InterCOrevih du Nord-Est. Piroth L, et al. Epidemiol Infect. 2011 Dec;139(12):1835-44. doi: 10.1017/S0950268810002980. Epub 2011 Jan 14. Epidemiol Infect. 2011. PMID: 21232172
Once-a-day HIV treatment: ready for prime time?
Sharp M, Clifton CE. Sharp M, et al. Posit Aware. 2002 Sep-Oct;13(5):44-7. Posit Aware. 2002. PMID: 12400495 No abstract available.
Regulatory issues in the era of highly active antiretroviral therapy.
Murray JS. Murray JS. AIDS. 2000;14 Suppl 3:S219-25. AIDS. 2000. PMID: 11086865 Review. No abstract available.
[Role of antiretroviral agents in the management of HIV infected people in Africa; scientific aspects of man and society. Recommendations of the Workshop of Gorée 2001].
[No authors listed] [No authors listed] Bull Soc Pathol Exot. 2002 Mar;95(1):53-7. Bull Soc Pathol Exot. 2002. PMID: 12012967 Review. French. No abstract available.

See all similar articles

Cited by

Using mechanistic models to simulate comparative effectiveness trials of therapy and to estimate long-term outcomes in HIV care.
Roberts MS, Nucifora KA, Braithwaite RS. Roberts MS, et al. Med Care. 2010 Jun;48(6 Suppl):S90-5. doi: 10.1097/MLR.0b013e3181e2b744. Med Care. 2010. PMID: 20473184 Free PMC article.
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007).
Wong WB, Ramsey SD, Barlow WE, Garrison LP Jr, Veenstra DL. Wong WB, et al. Contemp Clin Trials. 2012 Nov;33(6):1117-23. doi: 10.1016/j.cct.2012.08.006. Epub 2012 Aug 18. Contemp Clin Trials. 2012. PMID: 22981891 Free PMC article. Clinical Trial.
Methods in comparative effectiveness research.
Armstrong K. Armstrong K. J Clin Oncol. 2012 Dec 1;30(34):4208-14. doi: 10.1200/JCO.2012.42.2659. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071240 Free PMC article. Review.
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.
Goddard KA, Knaus WA, Whitlock E, Lyman GH, Feigelson HS, Schully SD, Ramsey S, Tunis S, Freedman AN, Khoury MJ, Veenstra DL. Goddard KA, et al. Genet Med. 2012 Jul;14(7):633-42. doi: 10.1038/gim.2012.16. Genet Med. 2012. PMID: 22516979 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information